Lamisil At

Terbinafine, the active ingredient in Lamisil At, is an allylamine presented as a topical formulation for cutaneous use. It treats common fungal skin infections such as athlete’s foot, jock itch and ringworm in both adults and children, and is indicated for superficial dermatophyte infections of the skin and nails.

GNH USA supplies Lamisil At as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable logistics for global distribution through a robust supply chain.

Terbinafine is an allylamine antifungal that targets dermatophyte infections of the skin.

Athlete’s foot (tinea pedis): reduces fungal growth and alleviates itching and scaling. Jock itch (tinea cruris): eliminates the causative fungus and improves skin comfort. Ringworm (tinea corporis): clears the infection and promotes healing of lesions.

Topical terbinafine may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Skin irritation: mild burning or stinging at the application site. - Itching: localized pruritus. - Redness: erythema around the treated area. - Dryness: peeling or flaking of the skin.

Serious or Rare Side Effects: - Allergic reaction: swelling, hives, or difficulty breathing. - Severe skin reaction: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Liver toxicity: abnormal liver function tests observed rarely with extensive use.

Before using Lamisil At, consider the following precautions to ensure safe and effective treatment.

- Pregnancy: consult a healthcare professional before application. - Breastfeeding: discuss potential risks with a physician. - Age: follow pediatric dosing recommendations if used in children. - Allergy: avoid if known hypersensitivity to terbinafine or other allylamines. - Application: apply to clean, dry skin and avoid contact with eyes. - Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Terbinafine can interact with other medicines; awareness of these interactions helps prevent adverse effects.

Major Interactions (Avoid): - Oral terbinafine: concurrent use may increase systemic exposure and toxicity. - Strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may raise terbinafine levels. - Warfarin: increased anticoagulant effect reported.

Moderate Interactions (Monitor Closely): - Oral contraceptives: efficacy may be reduced. - Antifungal agents (e.g., azoles): combined use can enhance irritation. - Alcohol: excessive intake may increase liver strain.